Reply to P. Kaul et al

Yasuhisa Hasegawa¹, Kiyoaki Tsukahara¹, Seiichi Yoshimoto¹+17

• ¹Yasuhisa Hasegawa, MD, PhD, Asahi University Hospital, Gifu, Japan; Kiyoaki Tsukahara, MD, PhD, Tokyo Medical University, Tokyo, Japan; Seiichi Yoshimoto, MD, PhD, National Cancer Center Hospital, Tokyo, Japan; Kouki Miura, MD, PhD, International University of Health and Welfare, Mita Hospital, Tokyo, Japan; Junkichi Yokoyama, MD, PhD, Nadogaya Hospital, Kashiwa, Japan; Shigeru Hirano, MD, PhD, Kyoto Prefectural University of Medicine, Kyoto, Japan; Hirokazu Uemura, MD, PhD, Nara Medical University, Kashihara, Japan; Masashi Sugasawa, MD, PhD, Saitama Medical University International Medical Center, Hidaka, Japan; Tomokazu Yoshizaki, MD, PhD, Graduate School of Medical Science, Kanazawa University, Kanazawa, Japan; Akihiro Homma, MD, PhD, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Sapporo, Japan; Kazuaki Chikamatsu, MD, PhD, Gunma University School of Medicine, Maebashi, Japan; Mikio Suzuki, MD, PhD, University of the Ryukyus Faculty of Medicine, Okinawa, Japan; Akihiro Shiotani, MD, PhD, National Defense Medical College, Tokorozawa, Japan; Takashi Matsuzuka, MD, PhD, Asahi University Hospital, Gifu, Japan; Naoyuki Kohno, MD, PhD, Kyorin University School of Medicine, Tokyo, Japan; Masakazu Miyazaki, MD, Nara Prefecture General Medical Center, Nara, Japan; Isao Oze, MD, PhD, and Keitaro Matsuo, MD, PhD, Aichi Cancer Center Research Institute, Nagoya Japan; Shigeru Kosuda, MD, PhD, Kouseikai General Clinic and Hospital, Kawagoe, Japan; and Yasushi Yatabe, MD, PhD, National Cancer Center Hospital, Tokyo, Japan.